Gustavo Caetano Corrêa

Dr. Gustavo Caetano Corrêa

orcid

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 August 2021 in Current Opinion in Immunology
Verified
Journal Article
Open access
Gilla K. ShapiroGilla K. Shapiro
Gilla K. Shapiro
JKJessica Kaufman
Jessica Kaufman
NBNoel T Brewer
Noel T Brewer
KWKerrie Wiley
Kerrie Wiley
LMLisa Menning
Lisa Menning
CWCharles S Wiysonge
Charles S Wiysonge
The World Health Organization and global partners sought to identify existing measures of confidence in childhood vaccines, as part of a broader effort to measure the range of behavioural and social drivers of vaccination. We identified 14 confidence measures applicable to childhood vaccination in general, all published between 2010 and 2019. The measures examined 1-5 constructs and included a mean of 12 items. Validation studies commonly examined factor structure, internal consistency reliability, and criterion-related validity. Fewer studies examined convergent and discriminant validity, test-retest reliability, or used cognitive interviewing. Most measures were developed and validated only in high-income countries. These findings highlight the need for a childhood vaccine confidence measure validated for use in diverse global contexts.

20 June 2017 in Conflict and Health
Verified
Journal Article
Open access
PDF file
GCGustavo Caetano Corrêa
Gustavo Caetano Corrêa
MDMrinalini Das
Mrinalini Das
RKRama Kovelamudi
Rama Kovelamudi
NJNagendra Jaladi
Nagendra Jaladi
CPCharlotte Pignon
Charlotte Pignon
PIPetros Isaakidis
Petros Isaakidis
With more than 200 million cases a year, malaria is an important global health concern, especially among pregnant women. The forested tribal areas of Andhra Pradesh, Telangana and Chhattisgarh in India are affected by malaria and by an on-going chronic conflict which seriously limits access to health care. The burden of malaria and anemia among pregnant women in these areas is unknown; moreover there are no specific recommendations for pregnant women in the Indian national malaria policy. The aim of this study is to measure the burden of malaria and anemia among pregnant women presenting in mobile clinics for antenatal care in a conflict-affected corridor in India. This is a descriptive study of routine programme data of women presenting at first visit for antenatal care in Médecins sans Frontières mobile clinics during 1 year (2015). Burden of malaria and anemia were estimated using rapid diagnostic tests (SD BIOLINE® and HemoCue® respectively). Among 575 pregnant women (median age: 26 years, interquartile range: 25-30) 29% and 22% were in their first and second pregnancies respectively. Mid-Upper Arm Circumference (MUAC) was below 230 mm in 74% of them. The prevalence of anemia was 92.4% (95% Confidence Intervals (CI): 89.9–94.3), while severe anemia was identified in 6.9% of the patients. The prevalence of malaria was 29.3% (95%CI: 25.7–33.2) with 64% caused by isolated P. falciparum, 35% by either P. falciparum or mixed malaria and 1% by either P. vivax, or P.malariae or P. ovale. Malaria test was positive in 20.8% of asymptomatic cases. Malaria was associated with severe anemia (prevalence ratio: 2.56, 95%CI: 1.40–4.66, p < 0.01). Systematic screening for malaria and anemia should be integrated into maternal and child health services for conflict affected populations in highly endemic tribal areas. Interventions should include the use of rapid diagnostic test for all pregnant women at every visit, regardless of symptoms. Further studies should evaluate the impact of this intervention alone or in combination with intermittent malaria preventive treatment.

1 June 2023 in Vaccine
Verified
Journal Article
Open access
MMMercy Mvundura
Mercy Mvundura
JNJunice Ng
Junice Ng
KRKatie Reynolds
Katie Reynolds
YNYee Theng Ng
Yee Theng Ng
JBJohn Bawa
John Bawa
JRJoanie Robertson
Joanie Robertson
Vaccine procurement costs comprise a significant share of immunization program costs in low- and middle-income countries, yet not all procured vaccines are administered. Vaccine wastage occurs due to vial breakage, excessive heat or freezing, expiration, or when not all doses in a multidose vial are used. Better estimates of vaccine wastage rates and their causes could support improved management of vaccine stocks and reduce procurement costs. This study examined aspects of wastage for four vaccines at service delivery points in Ghana (n = 48), Mozambique (n = 36), and Pakistan (n = 46). We used prospective data from daily and monthly vaccine usage data entry forms, along with cross-sectional surveys, and in-depth interviews. The analysis found that estimated monthly proportional open-vial wastage rates for vaccines in single-dose vials (SDV) or in multi-dose vials (MDV) that can be kept refrigerated up to four weeks after opening ranged from 0.08 % to 3 %. For MDV where remaining doses are discarded within six hours after opening, the mean wastage rates ranged from 5 % to 33 %, with rates being highest for measles containing vaccine. Despite national-level guidance to open a vaccine vial even when only one child is present, vaccines in MDV that are discarded within six hours of opening are sometimes offered less frequently than vaccines in SDV or in MDV where remaining doses can be used for up to 4 weeks. This practice can lead to missed opportunities for vaccination. While closed-vial wastage at service delivery points (SDPs) was relatively rare, individual instances can result in large losses, suggesting that monitoring closed-vial wastage should not be neglected. Health workers reported insufficient knowledge of vaccine wastage tracking and reporting methods. Improving reporting forms would facilitate more accurate reporting of all causes of wastage, as would additional training and supportive supervision. Globally, decreasing doses per vial could reduce open-vial wastage.

5 August 2025 in BMJ Global Health
Verified
Journal Article
Open access
PDF file
ABAudrey Beaulieu
Audrey Beaulieu
JDJoelle Ducharme
Joelle Ducharme
CTCéline Thibeault
Céline Thibeault
BABangaman Christian AKANI
Bangaman Christian AKANI
DZDaniela Ziegler
Daniela Ziegler
MJMira Johri
Mira Johri
Introduction: Intensified efforts are needed to achieve the Immunization Agenda 2030 (IA2030) target to halve the number of children not reached by routine vaccination (‘zero-dose’ (ZD) children) by 2030. This scoping review maps and synthesises the scientific literature on ZD children in low-income and middle-income countries since the IA2030 launch. Methods: Our protocol, developed per the PRISMA-ScR (Preferred Reporting Items for Systematic reviews and Meta-Analyses extension for Scoping Reviews) guidelines, was registered on the Open Science Framework prior to execution, and our search strategies were designed by a research librarian. We searched MEDLINE (Ovid), CINAHL Complete (EBSCOhost), EBM Reviews (Ovid), EMBASE (Ovid), LILACS and Google Scholar for peer-reviewed studies with quantitative evidence on ZD children published between January 2020 and January 2024. Using Covidence, we screened citations in a two-stage process by two independent reviewers and conducted data charting using a pretested form. Disagreements were resolved by consensus or consultation with a senior reviewer. Results: Of the 82 articles included, 73 provided evidence on prevalence, and/or distribution, 24 on barriers to vaccination services and 44 on deprivations faced by ZD children, their households and communities, with the risk of deprivations varying importantly across contexts. The barriers to vaccination most reported related to the intent to vaccinate (n=20), followed by community access (n=10). Deprivations mainly concerned access to health services, such as low utilisation of maternal health services (n=22), and other key development indicators, such as low socioeconomic status (n=29) and poor maternal education/literacy (n=28). We found no studies (n=0) on interventions focused on reaching ZD children with routine immunisation services. Conclusion: Our findings highlight the imperative to generate evidence on interventions delivering routine immunisation to ZD children and missed communities. Results also underscore the need for transformative approaches that address multiple deprivations using carefully selected, integrated services, tailored to context-specific needs.

28 January 2019 in Bulletin of the World Health Organization
Verified
Journal Article
Open access
GCGustavo Caetano Corrêa
Gustavo Caetano Corrêa
PVPhilippe Verstraete
Philippe Verstraete
RSRiswana Soundardjee
Riswana Soundardjee
MSManjari Shankar
Manjari Shankar
CPColin Paterson
Colin Paterson
HJHope Johnson
Hope Johnson

2 February 2023 in Vaccines
Verified
Journal Article
Open access
PDF file
JDJoelle Ducharme
Joelle Ducharme
GCGustavo Caetano Corrêa
Gustavo Caetano Corrêa
HRHeidi W. Reynolds
Heidi W. Reynolds
ASAlyssa Beth Sharkey
Alyssa Beth Sharkey
VFVirginia A. Fonner
Virginia A. Fonner
MJMira Johri
Mira Johri
Reaching zero-dose (ZD) children, operationally defined as children who have not received a first dose of the diphtheria, tetanus, and pertussis (DTP1) vaccine, is crucial to increase equitable immunisation coverage and access to primary health care. However, little is known about the approaches already taken by countries to improve immunisation equity. We reviewed all Health System Strengthening (HSS) proposals submitted by Gavi-supported countries from 2014 to 2021 inclusively and extracted information on interventions favouring equity. Pro-equity interventions were mapped to an analytical framework representing Gavi 5.0 programmatic guidance on reaching ZD children and missed communities. Data from keyword searches and manual screening were extracted into an Excel database. Open format responses were analysed using inductive and deductive thematic coding. Data analysis was conducted using Excel and R. Of the 56 proposals included, 51 (91%) included at least one pro-equity intervention. The most common interventions were conducting outreach sessions, tailoring the location of service delivery, and partnerships. Many proposals had “bundles” of interventions, most often involving outreach, microplanning and community-level education activities. Nearly half prioritised remote-rural areas and only 30% addressed gender-related barriers to immunisation. The findings can help identify specific interventions on which to focus future evidence syntheses, case studies and implementation research and inform discussions on what may or may not need to change to better reach ZD children and missed communities moving forward.